Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
about
The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genesThe impact of environmental factors in severe psychiatric disorders.Kynurenines in CNS disease: regulation by inflammatory cytokinesPregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice.Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and functionmicroRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorderInteractions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophreniaAssociation between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblingsPharmacology of hallucinations: several mechanisms for one single symptom?Evidence for X-chromosomal schizophrenia associated with microRNA alterationsDopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorderProgressive pathology is functionally linked to the domains of language and emotion: meta-analysis of brain structure changes in schizophrenia patientsAltered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophreniad-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophreniaDisrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with MitofilinNucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expressionDysbindin-1 is a synaptic and microtubular protein that binds brain snapinThe chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR functionEffect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatmentLRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophreniaGeneration and characterization of Rgs4 mutant miceFunctional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brainBipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent triosReinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding proteinp90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling.Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the diseaseIdentifying gene regulatory networks in schizophreniaPositive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortexReplication of association between working memory and Reelin, a potential modifier gene in schizophreniaCatechol-O-methyltransferase polymorphisms and some implications for cognitive therapeuticsHeritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.Specific regulation of NRG1 isoform expression by neuronal activityDe novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in DrosophilaMutant mouse models: genotype-phenotype relationships to negative symptoms in schizophreniaDISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphismsGene-environment interactions in schizophrenia: review of epidemiological findings and future directionsStructural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaMechanisms of neuregulin action
P2860
Q21092132-55229DD3-5E0B-44D2-B063-42B31ED8936CQ21129355-66CFFC8D-DA18-49DB-AD4D-2EE263641241Q21129356-1FEDF96D-6334-4747-921D-C825E75E92C4Q21133801-279390FF-7430-47D1-915A-2D67AD487FE3Q21145031-5D43177C-B9C1-43A5-ACA0-D6F6402C55C4Q21184126-177518F8-8C41-4FAA-B632-0522AF6C40D7Q21203806-33226904-83C3-41CD-8B86-1D9784FB3C0EQ21203814-97AF68B8-1EEE-4735-A7FD-257364105070Q21284720-CC99CD54-9C35-48CF-BDDC-23066465749DQ21562396-0E13E9BB-E4F7-42B0-A6B0-E99C30BDEEE4Q22242334-50137BEE-6F85-4764-AEF5-C81B1C79271BQ24174832-3DAD917A-A3E8-49C3-8CC2-58AACD2C4875Q24293245-1B6DB227-9CED-4B96-B29D-7A27DDE4CEEFQ24294371-9DFB0272-8503-409D-9473-E3C1D44B1E58Q24301405-DFDEB708-F919-4FFB-8A79-BF4AB06F4A22Q24301877-9602FAEA-63F7-4A48-9104-BD71E2BAC876Q24303507-94B17F9A-84D1-4344-A34D-9887C7FDC91FQ24308763-5A4A0FC2-61EC-4E6D-BAC8-263DFC2DD4AFQ24316880-7CCFFCC4-D914-49BF-8789-39E62C684A99Q24324059-C377751D-4F20-4BF5-B35A-10225654016EQ24523661-4427E6C2-9969-4FFC-9F64-AE69B58C9115Q24534089-523C85C5-B242-48C5-B6BC-4BF9272954C2Q24538580-A8734EFB-1D60-4037-8727-E125363A0188Q24543935-CBF46109-0544-4564-8AD4-D2D1855AB7FFQ24545327-742FBF61-C13D-4777-A939-676CC903C961Q24546782-A216A9CA-E044-4BE7-B7B0-43724C7D45B8Q24601410-4DC3AF02-3E37-4BE1-A751-96D2250FF722Q24602550-A52A6C12-8ACF-48D4-8467-037FFA0B0BE1Q24606481-0C8C70BC-9FE7-41EE-8C80-6C29506F8990Q24608073-C9E199A2-B743-444A-9ABC-7B9867CB1ED7Q24612495-66747616-4B81-44E5-9383-3C3D5916FFCCQ24618674-6259D6E6-88B8-4CC8-A3B0-337E4AB5C19FQ24621518-D2FE1FF0-F191-4E27-A02A-B16BADD74BADQ24625434-C527DCE5-011A-4E67-A95D-DAAA96EF3F9EQ24632939-E511B797-FE2E-4960-AE8C-63D0A97267F8Q24643052-249DA7C6-5D76-4126-A8DB-0D2023662701Q24643775-609F342D-E335-4192-9745-5469726D9A74Q24643863-396F473A-E6AF-497B-9DB0-A257720B0374Q24646206-73F52A8F-AC43-42A3-9972-D13B1A06E0A3Q24650665-AE10E1B0-72BD-41D8-B684-5FE147A09FF0
P2860
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Schizophrenia genes, gene expr ...... he matter of their convergence
@ast
Schizophrenia genes, gene expr ...... he matter of their convergence
@en
type
label
Schizophrenia genes, gene expr ...... he matter of their convergence
@ast
Schizophrenia genes, gene expr ...... he matter of their convergence
@en
prefLabel
Schizophrenia genes, gene expr ...... he matter of their convergence
@ast
Schizophrenia genes, gene expr ...... he matter of their convergence
@en
P2860
P3181
P356
P1433
P1476
Schizophrenia genes, gene expr ...... he matter of their convergence
@en
P2093
Harrison PJ
P2860
P2888
P304
40-68; image 5
P3181
P356
10.1038/SJ.MP.4001558
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1036287924